至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Sensitization potential of medical devices detected by in vitro and in vivo methods

ALTEX. 2021-01; 
Lada Svobodová, Marian Rucki, Alena Vlkova, Kristina Kejlova, Dagmar Jírová, Marketa Dvorakova, Hana Kolarova, Helena Kandárová, Peter Pôbiš, Tuula Heinonen, Marek Maly
Products/Services Used Details Operation
Peptide Synthesis … of tested samples to the measured activity of the negative control (acetonitrile). Peptides containing cysteine were prepared and purified by GenScript (Piscataway, NJ). Briefly, 50 µl and 250 µl of the tested extract was mixed … Get A Quote

摘要

Medical devices have to be tested before marketing in accordance with ISO EN 10993-10 in order to avoid skin sensitization. This standard predominantly refers to the in vivo test; however, it doesn't exclude the use of in vitro methods, which have been sufficiently technically and scientifically validated for the purpose of medical devices testing. It is foreseen that due to the complexity of the sensitization endpoint, combination of several methods will be needed to address all key events occurring in the sensitization process. The objective of this pilot study was to evaluate sensitization potential of selected medical devices using a combination of in vitro (LuSens, OECD TG 442D), in chemico (DPRA, OECD TG ... More

关键词

mechanistic-based risk assessment, extracts, in vitro and in vivo toxicology, medical devices, public health, skin sensitization